title: PHARMAC's updated guidelines for cost-effectiveness analyses, with new discount rate.
authors.forename: Rachel
authors.initials: R
authors.lastname: Grocott
authors.forename: Scott
authors.initials: S
authors.lastname: Metcalfe
mesh_terms: D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D017408:Guidelines as Topic; D006801:Humans; D009520:New Zealand